Fulgent Genetics, Inc. (FLGT)
24.05
-0.73
(-2.95%)
USD |
NASDAQ |
Nov 20, 10:22
Fulgent Genetics Cash from Investing (Quarterly) : -48.04M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -48.04M |
| June 30, 2026 | 50.80M |
| March 31, 2026 | 10.94M |
| December 31, 2025 | 11.15M |
| September 30, 2025 | 19.08M |
| June 30, 2025 | 53.40M |
| March 31, 2025 | 27.73M |
| December 31, 2024 | -27.46M |
| September 30, 2024 | 8.985M |
| June 30, 2024 | 7.304M |
| March 31, 2024 | -47.19M |
| December 31, 2023 | 24.27M |
| September 30, 2023 | 20.08M |
| June 30, 2023 | -1.096M |
| March 31, 2023 | -4.354M |
| December 31, 2022 | -92.60M |
| September 30, 2022 | 44.29M |
| June 30, 2022 | -213.69M |
| March 31, 2022 | 0.688M |
| December 31, 2021 | -140.27M |
| September 30, 2021 | -34.78M |
| June 30, 2021 | -155.00M |
| Date | Value |
|---|---|
| March 31, 2021 | -216.49M |
| December 31, 2020 | -318.77M |
| September 30, 2020 | -1.404M |
| June 30, 2020 | -2.405M |
| March 31, 2020 | -3.862M |
| December 31, 2019 | -36.08M |
| September 30, 2019 | 6.344M |
| June 30, 2019 | 3.211M |
| March 31, 2019 | -2.522M |
| December 31, 2018 | -2.536M |
| September 30, 2018 | 4.962M |
| June 30, 2018 | -1.527M |
| March 31, 2018 | 0.051M |
| December 31, 2017 | -1.763M |
| September 30, 2017 | -2.568M |
| June 30, 2017 | 4.152M |
| March 31, 2017 | -1.87M |
| December 31, 2016 | -39.42M |
| September 30, 2016 | -2.816M |
| June 30, 2016 | -0.386M |
| March 31, 2016 | -0.177M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -169.00M |
| Labcorp Holdings, Inc. | -433.70M |
| OPKO Health, Inc. | 11.30M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -11.85M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 109.23M |
| Cash from Financing (Quarterly) | -0.724M |
| Free Cash Flow | -1.40M |
| Free Cash Flow Per Share (Quarterly) | 3.884 |
| Free Cash Flow to Equity (Quarterly) | 106.68M |
| Free Cash Flow to Firm (Quarterly) | 107.45M |
| Free Cash Flow Yield | -0.21% |